All Pharma News
Clarity receives FDA Fast Track Designation for 64Cu-SAR-bisPSMA

Clarity receives FDA Fast Track Designation for 64Cu-SAR-bisPSMA
PR NEWSWIRE
22 Aug 2024
Share Share
NorthStar Medical Radioisotopes Enters Clinical Supply Pact

NorthStar Medical Radioisotopes Enters Clinical Supply Pact
CONTRACTPHARMA
10 Apr 2024
Share Share
First Participant Treated Using NorthStar Med Radioisotopes’ (Cu-67)

First Participant Treated Using NorthStar Med Radioisotopes’ (Cu-67)
BUSINESSWIRE
28 Aug 2023
Share Share
First participant treated at the highest dose level in Clarity`s mCRPC trial

First participant treated at the highest dose level in Clarity`s mCRPC trial
PR NEWSWIRE
25 Aug 2023
Share Share
Clarity establishes a US Center of Excellence for Targeted Copper Theranostics

Clarity establishes a US Center of Excellence for Targeted Copper Theranostics
PR NEWSWIRE
28 Jun 2023
Share Share
Clarity commences COMBAT theranostic prostate cancer trial in the US

Clarity commences COMBAT theranostic prostate cancer trial in the US
PR NEWSWIRE
20 Jun 2023
Share Share
Clarity completes first stage of prostate cancer trial

Clarity completes first stage of prostate cancer trial
CLINICAL TRIALS ARENA
25 May 2023
Share Share
IND approval from FDA for theranostic SAR-Bombesin trial in prostate cancer

IND approval from FDA for theranostic SAR-Bombesin trial in prostate cancer
PRNEWSWIRE
21 Nov 2022
Share Share
Clarity begins subject dosing in prostate cancer therapy trial

Clarity begins subject dosing in prostate cancer therapy trial
CLINICALTRIALSARENA
10 Oct 2022
Share Share
First patient treated in Clarity`s therapeutic prostate cancer trial

First patient treated in Clarity`s therapeutic prostate cancer trial
PRNEWSWIRE
07 Oct 2022
Share Share